Gibco™ CTS™ Synth-a-Freeze™ Medium

Description

• CTS™ (Cell Therapy Systems) Synth-a-Freeze™ medium is a chemically defined, protein-free liquid cryopreservation medium intended for freezing and storing a variety of mammalian cell types including stem cells
• Synth-a-Freeze™ CTS™ media is optimally formulated without antibiotics, antimycotics, hormones, growth factors, serum, or protein and buffered with HEPES and sodium bicarbonate
• • Use for cryopreserving a variety of primary and stem cells • Save time and effort with 4 degree stable storage of thawed media and compatibility with a variety freezing protocols • Be ready for clinical research with this cGmP manufactured, chemically defined, protein-free formula Cryopreserve a Variety of Cell Types Cell Therapy Systems Synth-a-Freeze™ CTS™ media performs comparable to our standard, serum-containing cryopreservation medium for cryopreserving a variety of cell types including human Embryonic Stem Cells, Neural Stem Cells (Ref 1), Mesenchymal Stem Cells and Keratinocytes (Ref 2)
• We do not recommend using Synth-a-Freeze™ media for cryopreservation of human epidermal melanocytes
• Simple Incorporation into Your Current Freezing Protocol Synth-a-Freeze™ CTS™ media can be used with any standard freezing protocol
• Just add thawed Cell Therapy Systems Synth-a-Freeze™ CTS™ media to detached and pelleted cells, aliquot, and freeze
• For optimal results, the use of a controlled-rate freezer is recommended
• Simplify Your Transition into Clinical Research The Gibco™ Cell Therapy Systems (CTS™) brand offers a broad array of products for use in cell therapy applications, including media, reagents, growth factors, enzymes, cell selection/expansion reagents, and devices
• Gibco™ Cell Therapy Systems (CTS™) products deliver: • Reduced burden in qualifying reagents • Included appropriate certificates of analyses and origin • Convenient access to our Drug Master File (DMF) For Research Use or Manufacturing of Cell, Gene, or Tissue-Based Products
• CAUTION: Not intended for direct administration into humans or animals References: • S
• Shin and M
• Vemuri
• Culture and Differentiation of Human Neural Stem Cells
• L.C
• Doering (ed)
• Protocols for Neural Cell Culture
• Springer Protocol Handbooks
• • S
• Lemaire, K
• Kosowska-Shick, P
• Appelbaum, G
• Verween, P
• Tulkens, and F
• Van Bambeke
• Cellular Pharmacodynamics of the Novel Biaryloxazolidinone Radezolid: Studies with Infected Phagocytic and Nonphagocytic cells, Using Staphylococcus aureus, Staphylococcus epidermidis, Listeria monocytogenes, and Legionella pneumophila
• Antimicrob Agents Chemother 54(6) 2010: 2549-2559.